NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it is
investigating potential securities claims on behalf of investors of
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) resulting from allegations
that Adamas may have issued materially misleading business information
to the investing public.
Adamas completed its Second Public Offering in January 2018 (“SPO”),
offering shares at $41.50 per share. Prior to the launch of Adamas’ drug
Gocovri, a medicine used to treat dyskinesia in Parkinson’s disease
patients treated with levodopa therapy, Adamas knew it had substantial
roadblocks that would dramatically reduce Adamas’ ability to sell
Gocovri. Adamas failed to disclosed these problems in its SPO and thus,
misled the market. In October 2018, Merrill Lynch released a study which
casted serious doubt on Gocovri’s ability to achieve a sizeable market
share and emphasized that Adamas failed to include critical information.
In March 2019, Adamas backtracked on prior issued growth estimates and
no longer made predictions regarding Gocovri’s ability to achieve a
sizeable market share. As a result, Adamas’ stock price plummeted well
below the price of the SPO.
Rosen Law Firm is preparing a class action lawsuit to recover losses
suffered by Adamas investors. If you purchased shares of Adamas, please
visit the firm’s website at https://www.rosenlegal.com/cases-register-1584.html
to join the class action. You may also contact Phillip Kim of Rosen Law
Firm toll free at 866-767-3653 or via email at [email protected]
or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm,
on Twitter: https://twitter.com/rosen_firm
or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since
2013. Rosen Law Firm has secured hundreds of millions of dollars for
investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contacts
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275
Madison Avenue, 34th Floor
New York, NY 10016
Tel:
(212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
